These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3690224)

  • 21. [Prognostic value of hormone receptor in breast cancer].
    Yamamoto H; Morimoto T; Komaki K; Inui K; Ohshimo K; Tanaka T; Monden Y
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):96-101. PubMed ID: 3821719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative estrogen and progesterone receptor levels related to progression-free interval in advanced breast cancer patients treated with megestrol acetate or tamoxifen.
    Bonomi P; Gale M; Von Roenn J; Anderson K; Johnson P; Wolter J; Economou S
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):26-33. PubMed ID: 3368797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The correlation between estrogen and progesterone receptors and some clinical and pathological features in human breast cancer.
    Caldarola L; Volterrani P; Lai M; Vigezzi P; Gaglia P
    Ital J Surg Sci; 1985; 15(4):329-33. PubMed ID: 3830952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of prognostic factors in operable breast cancer.
    Hawkins RA; Tesdale AL; Killen ME; Jack WJ; Chetty U; Dixon JM; Hulme MJ; Prescott RJ; McIntyre MA; Miller WR
    Br J Cancer; 1996 Nov; 74(9):1469-78. PubMed ID: 8912547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone receptors as prognostic factors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Ann Med; 1991 Dec; 23(6):643-8. PubMed ID: 1777219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.
    Alexieva-Figusch J; Van Putten WL; Blankenstein MA; Blonk-Van Der Wijst J; Klijn JG
    Cancer; 1988 Feb; 61(4):758-68. PubMed ID: 3338038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of hormone receptors in breast cancer.
    Morimoto T; Komaki K; Yamamoto H; Yamakawa T; Tanaka T; Sonoo H; Monden Y
    J Surg Oncol; 1988 Oct; 39(2):101-7. PubMed ID: 3172790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of progesterone receptors alone or in association with estrogen receptors in human breast cancer.
    Di Fronzo G; Cappelletti V; Coradini D; Ronchi E; Scavone G
    Tumori; 1984 Apr; 70(2):159-64. PubMed ID: 6730014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic Characteristics of Oestrogen Receptor-Positive/Progesterone Receptor-Negative/Her2-Negative Breast Cancer According to a Novel Definition of Negative Progesterone Receptor Status: A Large Population-Based Study from China.
    Li AQ; Zhou SL; Li M; Xu Y; Shui RH; Yu BH; Yang WT
    PLoS One; 2015; 10(5):e0125067. PubMed ID: 25938238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Steroid hormone receptors in breast cancer].
    Nomura Y
    Rinsho Byori; 1990 Jan; 38(1):26-30. PubMed ID: 2308219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor-negative progesterone receptor-positive breast cancer - "Nobody's land" or just an artifact?
    Kunc M; Biernat W; Senkus-Konefka E
    Cancer Treat Rev; 2018 Jun; 67():78-87. PubMed ID: 29772460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of hormone receptors of breast cancer cells for the duration of a disease-free interval].
    Zielinski CC; Kuzmits R; Kubista E; Salzer H; Staffen A; Aiginger P; Spona J
    Wien Klin Wochenschr; 1985 May; 97(11):493-7. PubMed ID: 4013343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oestrogen receptors, clinical features and prognosis in stage III breast cancer.
    Stewart JF; King RJ; Winter PJ; Tong D; Hayward JL; Rubens RD
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1315-20. PubMed ID: 6891930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer.
    Thorpe SM; Christensen IJ; Rasmussen BB; Rose C
    Eur J Cancer; 1993; 29A(7):971-7. PubMed ID: 8499151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrence.
    Bogina G; Lunardi G; Coati F; Zamboni G; Gori S; Bortesi L; Marconi M; Cassandrini PA; Turazza M; Cortesi L; DeMatteis E; Ficarra G; Ibrahim T; Serra P; Medri L; Giraudi S; Lambertini M; Carli F; Foglietta J; Sidoni A; Nunzi M; Ficorella C; Diadema MR; Del Mastro L
    Tumori; 2015; 101(4):398-403. PubMed ID: 26045108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictive power of progesterone receptor status in early breast carcinoma.
    Sutton R; Campbell M; Cooke T; Nicholson R; Griffiths K; Taylor I
    Br J Surg; 1987 Mar; 74(3):223-6. PubMed ID: 3567519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.